TY - JOUR
T1 - RD-Connect, NeurOmics and EURenOmics
T2 - collaborative European initiative for rare diseases
AU - Lochmüller, Hanns
AU - Badowska, Dorota M
AU - Thompson, Rachel
AU - Knoers, Nine V
AU - Aartsma-Rus, Annemieke
AU - Gut, Ivo
AU - Wood, Libby
AU - Harmuth, Tina
AU - Durudas, Andre
AU - Graessner, Holm
AU - Schaefer, Franz
AU - Riess, Olaf
N1 - Funding Information:
Acknowledgements This work has received funding from the European Community’s Seventh Framework Program (FP7/2007–2013) under grant agreement n° 305444 “RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research”, grant agreement n° 2012-305121 “Integrated European –omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases (NEUROMICS)” and n° 305608 “EURenOmics”. Hanns Lochmüller has received funding from the Medical Research Council UK (grant reference G1002274, grant ID 98482). We would like to thank Victoria Hedley for her support in dissemination of the RD-Connect project and Ana Töpf for her feedback, which helped to develop the Genome-Phenome Analysis Platform.
Publisher Copyright:
© The Author(s) 2018.
PY - 2018/6
Y1 - 2018/6
N2 - Although individually uncommon, rare diseases (RDs) collectively affect 6-8% of the population. The unmet need of the rare disease community was recognized by the European Commission which in 2012 funded three flagship projects, RD-Connect, NeurOmics, and EURenOmics, to help move the field forward with the ambition of advancing -omics research and data sharing at their core in line with the goals of IRDiRC (International Rare Disease Research Consortium). NeurOmics and EURenOmics generate -omics data and improve diagnosis and therapy in rare renal and neurological diseases, with RD-Connect developing an infrastructure to facilitate the sharing, systematic integration and analysis of these data. Here, we summarize the achievements of these three projects, their impact on the RD community and their vision for the future. We also report from the Joint Outreach Day organized by the three projects on the 3rd of May 2017 in Berlin. The workshop stimulated an open, multi-stakeholder discussion on the challenges of the rare diseases, and highlighted the cross-project cooperation and the common goal: the use of innovative genomic technologies in rare disease research.
AB - Although individually uncommon, rare diseases (RDs) collectively affect 6-8% of the population. The unmet need of the rare disease community was recognized by the European Commission which in 2012 funded three flagship projects, RD-Connect, NeurOmics, and EURenOmics, to help move the field forward with the ambition of advancing -omics research and data sharing at their core in line with the goals of IRDiRC (International Rare Disease Research Consortium). NeurOmics and EURenOmics generate -omics data and improve diagnosis and therapy in rare renal and neurological diseases, with RD-Connect developing an infrastructure to facilitate the sharing, systematic integration and analysis of these data. Here, we summarize the achievements of these three projects, their impact on the RD community and their vision for the future. We also report from the Joint Outreach Day organized by the three projects on the 3rd of May 2017 in Berlin. The workshop stimulated an open, multi-stakeholder discussion on the challenges of the rare diseases, and highlighted the cross-project cooperation and the common goal: the use of innovative genomic technologies in rare disease research.
KW - Journal Article
KW - Berlin
KW - Humans
KW - Proteomics/trends
KW - Rare Diseases/epidemiology
KW - International Cooperation
KW - Research
KW - Information Dissemination
UR - http://www.scopus.com/inward/record.url?scp=85042563648&partnerID=8YFLogxK
U2 - 10.1038/s41431-018-0115-5
DO - 10.1038/s41431-018-0115-5
M3 - Review article
C2 - 29487416
SN - 1018-4813
VL - 26
SP - 778
EP - 785
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
IS - 6
ER -